Pathogenesis of the cardiometabolic risk in youth with type 1 diabetes
Conditions
Diabetes Mellitus - Type 1
Volunteers
Health Professionals
What is the purpose of this trial?
Brief Summary:
The purpose of this study is to quantitate hepatic de novo lipogenesis (DNL) in youth with poorly-controlled type 1 diabetes (T1D) (HbA1c >8.5%), youth with T1D who achieve targeted glycemic control (HbA1c <7.5%) and lean controls. Hypothesis: Youth with poor glycemic control experience higher fractional hepatic DNL during the fasting and the postprandial states than youth who achieve targeted glycemic control and lean controls.
- Ages13 years - 22 years
- GenderBoth
- Trial withJuvenile Diabetes Research Foundation International
- Start Date11/20/2019
- End Date09/30/2021
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigators
- Last Updated03/27/2022
- Study HIC#2000025170